| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Bonstein Sara is a Chief Financial Officer at Ayala Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $9.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2017 | ADXS Ayala Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,862 | $3.30 | $12,744.60 | -1.7% | |
| Nov 2, 2017 | ADXS Ayala Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 12,734 | $3.19 | $40,621.46 | -5.2% | |
| Dec 30, 2016 | ADXS Ayala Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 5,520 | $7.37 | $40,682.40 | -4.2% | |
| Feb 24, 2016 | ADXS Ayala Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 15,037 | $5.58 | $83,906.46 | -15.8% |